You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Pulmonology
ERS 2023 | Heterogeneity of Inflammatory Pathways in COPD
Dr. Stephanie Christenson shares an overview of inflammatory pathways underlying COPD, including type 2 inflammation.
MAS, MD
Stephanie Christenson
Learning objectives
- Describe the clinical consequences of COPD through an understanding of pathological changes
- Understand the spectrum of inflammatory pathways and the role of type 2 inflammation in COPD pathophysiology
Description
Join Klaus Rabe, MD, PhD, and Stephanie Christenson, MD, PhD, as they dive into the intricate relationship between clinical presentation and disease pathology in COPD and shed light on the diverse inflammatory pathways that contribute to its heterogeneity. Their discussion offers valuable insights into understanding the complexity of inflammatory mechanisms driving COPD.
Tags
MAT-US-2401136 v1.0 - P Exp Date: 11/28/2025
About this expert
Pulmonology
Stephanie Christenson
MAS, MD
Associate Professor at the University of California, San Francisco in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine
See author’s profileRelated resources
